Annual EBITDA
-$450.13M$89.73M-24.90%
Summary
- Current Value
- As of today, MDGL annual EBITDA is -$450.13M, down -24.90% on
- Historical Performance
- MDGL annual EBITDA is down -86.43% over the past 3 years, and down -374.52% over the past 5 years
- All-Time High Comparison
- MDGL annual EBITDA is currently -642.30% below its historical high of $83.00M set on
- 3-Year Low Comparison
- MDGL annual EBITDA is at its 3-year low
- Sector Comparison
- MDGL annual EBITDA is higher than 1.95% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$450.13M | -24.9% | -86.4% | -374.5% | -642.3% | |
| Quarterly EBITDA | -$113.62M | +2.1% | -41.5% | -93.7% | -1064.3% | |
| TTM EBITDA | -$306.01M | +44.1% | -12.3% | -73.2% | -812.7% | |
| Price | $510.53 | +50.6% | +69.7% | +356.2% | +116.1% | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $180.13M | +100.0% | +100.0% | +100.0% | +24.9% | |
| Annual EPS | -$21.90 | -9.5% | -49.7% | -301.6% | -127.0% | |
| Annual EBIT | -$451.22M | -25.0% | -86.6% | -375.1% | -660.2% | |
| Annual Net Income | -$465.89M | -24.7% | -92.6% | -455.0% | -689.1% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$290.92M | N/A | -54.7% |
| 5Y | -$206.20M | N/A | -118.3% |
| All | $83.00M | -642.3% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$450.13M | at low | |
| 5Y | -$450.13M | at low | |
| All | -$450.13M | at low |
EBITDA History
FAQ
What is the current annual EBITDA of MDGL?
As of today, MDGL annual EBITDA is -$450.13M
What is 1-year change in MDGL annual EBITDA?
MDGL annual EBITDA is down -24.90% year-over-year
What is 3-year change in MDGL annual EBITDA?
MDGL annual EBITDA is down -86.43% over the past 3 years
How far is MDGL annual EBITDA from its all-time high?
MDGL annual EBITDA is currently -642.30% below its historical high of $83.00M set on December 31, 2009
How does MDGL annual EBITDA rank versus sector peers?
MDGL annual EBITDA is higher than 1.95% of companies in Healthcare sector
When is MDGL next annual earnings release?
The next annual earnings release for MDGL is on
Quarterly EBITDA
-$113.62M$66.79M-142.64%
Summary
- Current Value
- As of today, MDGL quarterly EBITDA is -$113.62M, down -142.64% on
- Historical Performance
- MDGL quarterly EBITDA is up +2.06% year-over-year, and down -41.51% over the past 3 years
- All-Time High Comparison
- MDGL quarterly EBITDA is currently -195.66% below its historical high of $118.78M set on
- 3-Year Low Comparison
- MDGL quarterly EBITDA is +29.98% above its 3-year low of -$162.27M reached on
- Sector Comparison
- MDGL quarterly EBITDA is higher than 2.53% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$113.62M | -142.6% | +2.1% | -41.5% | -93.7% | |
| Annual EBITDA | -$450.13M | – | -24.9% | -86.4% | -374.5% | |
| TTM EBITDA | -$306.01M | +0.8% | +44.1% | -12.3% | -73.2% | |
| Price | $510.53 | +18.8% | +50.6% | +69.7% | +356.2% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $287.27M | +35.0% | +362.0% | +100.0% | +100.0% | |
| Quarterly EPS | -$5.08 | -166.8% | -3.3% | -7.0% | -35.4% | |
| Quarterly EBIT | -$113.98M | -141.5% | +2.0% | -41.7% | -93.9% | |
| Quarterly Net Income | -$114.19M | -170.1% | -6.8% | -40.6% | -97.0% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$46.83M | -142.6% | |
| 3Y | -$46.83M | -142.6% | |
| 5Y | -$46.83M | -142.6% | |
| All | $118.78M | -195.7% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$113.62M | at low | |
| 3Y | -$162.27M | +30.0% | |
| 5Y | -$162.27M | +30.0% | |
| All | -$162.27M | +30.0% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of MDGL?
As of today, MDGL quarterly EBITDA is -$113.62M
What is MDGL quarterly EBITDA most recent change?
MDGL quarterly EBITDA was down -142.64% on September 30, 2025
What is 1-year change in MDGL quarterly EBITDA?
MDGL quarterly EBITDA is up +2.06% year-over-year
How far is MDGL quarterly EBITDA from its all-time high?
MDGL quarterly EBITDA is currently -195.66% below its historical high of $118.78M set on September 30, 2009
How does MDGL quarterly EBITDA rank versus sector peers?
MDGL quarterly EBITDA is higher than 2.53% of companies in Healthcare sector
When is MDGL next earnings release?
The next earnings release for MDGL is on
TTM EBITDA
-$306.01M$2.39M+0.77%
Summary
- Current Value
- As of today, MDGL TTM EBITDA is -$306.01M, up +0.77% on
- Historical Performance
- MDGL TTM EBITDA is up +44.08% year-over-year, and down -12.33% over the past 3 years
- All-Time High Comparison
- MDGL TTM EBITDA is currently -419.54% below its historical high of $95.77M set on
- 3-Year Low Comparison
- MDGL TTM EBITDA is +44.08% above its 3-year low of -$547.18M reached on
- Sector Comparison
- MDGL TTM EBITDA is higher than 3.89% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$306.01M | +0.8% | +44.1% | -12.3% | -73.2% | |
| Annual EBITDA | -$450.13M | – | -24.9% | -86.4% | -374.5% | |
| Quarterly EBITDA | -$113.62M | -142.6% | +2.1% | -41.5% | -93.7% | |
| Price | $510.53 | +18.8% | +50.6% | +69.7% | +356.2% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $740.64M | +43.7% | +864.2% | +100.0% | +100.0% | |
| TTM EPS | -$13.01 | -1.3% | +48.1% | +18.8% | -17.5% | |
| TTM EBIT | -$307.49M | +0.8% | +43.9% | -12.7% | -73.7% | |
| TTM Net Income | -$289.13M | -2.6% | +44.3% | -5.5% | -69.2% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$306.01M | at high | |
| 3Y | -$293.10M | N/A | -4.4% |
| 5Y | -$206.20M | N/A | -48.4% |
| All | $95.77M | -419.5% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$496.78M | N/A | +38.4% |
| 3Y | -$547.18M | +44.1% | |
| 5Y | -$547.18M | +44.1% | |
| All | -$547.18M | +44.1% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of MDGL?
As of today, MDGL TTM EBITDA is -$306.01M
What is MDGL TTM EBITDA most recent change?
MDGL TTM EBITDA was up +0.77% on September 30, 2025
What is 1-year change in MDGL TTM EBITDA?
MDGL TTM EBITDA is up +44.08% year-over-year
How far is MDGL TTM EBITDA from its all-time high?
MDGL TTM EBITDA is currently -419.54% below its historical high of $95.77M set on March 31, 2010
How does MDGL TTM EBITDA rank versus sector peers?
MDGL TTM EBITDA is higher than 3.89% of companies in Healthcare sector
When is MDGL next earnings release?
The next earnings release for MDGL is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- MDGL Official Website www.madrigalpharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1157601/000162828025048559/0001628280-25-048559-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1157601/000162828025007980/0001628280-25-007980-index.htm
- MDGL Profile on Yahoo Finance finance.yahoo.com/quote/MDGL
- MDGL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mdgl